SPDR S&P Pharmaceuticals ETF
XPH
XPH
85 hedge funds and large institutions have $335M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 7 closing their positions.
Holders
85
Holders Change
+6
Holders Change %
+7.59%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
30
Reduced
26
Closed
7
Calls
$1.27M
Puts
$511K
Net Calls
+$761K
Net Calls Change
+$847K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$29.9M |
| 2 |
2
Morgan Stanley
New York
|
$73.6M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$2.97M |
| 4 |
SI
4
Stephens Inc
Little Rock,
Arkansas
|
$6.01M |
| 5 |
DC
5
Davenport & Co
Richmond,
Virginia
|
$3.4M |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$11.7M |
| 2 |
2
SG Americas Securities
New York
|
$285K |
| 3 |
NCM
3
Niemann Capital Management
Stateline,
Nevada
|
$7.75M |
| 4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$6.93M |
| 5 |
5
Jane Street
New York
|
$497K |
